Robert Hemley

Co-founder, COO and Member of the Board. Mr. Hemley has been a consultant to the biotechnology and pharmaceutical industry for 24 years and has worked on projects across geographical markets, therapeutic areas for small and large companies. He has also been involved in the formation of several new companies including the Immune Response Corporation, Cortex Pharmaceuticals, Auriga Pharmaceuticals, and CureMark. Mr. Hemley has been involved with assisting startup biotech companies in setting strategic direction, market assessment and tactical planning. He has worked with mid-size companies in setting priorities, assessing potential science and technology, defining strategic and tactical paths. He has also worked with large pharmaceutical companies in technology assessment and due diligence. Mr. Hemley received his graduate and post-graduate degree from University of Vermont and obtained his Business education from Lubin School of Business, Pace University.